Where does Tetraphase Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tetraphase Pharmaceuticals, Inc. ranks #23,517 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tetraphase Pharmaceuticals, Inc. hold?

Tetraphase Pharmaceuticals, Inc. holds 12 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Tetraphase Pharmaceuticals, Inc.'s Innovation Score?

Tetraphase Pharmaceuticals, Inc. has an Innovation Score of 26.9 out of 100 (top 78% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Tetraphase Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Tetraphase Pharmaceuticals, Inc.'s recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Tetraphase Pharmaceuticals, Inc.'s patents?

Tetraphase Pharmaceuticals, Inc.'s patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tetraphase Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tetraphase Pharmaceuticals, Inc.

Q: What technology areas does Tetraphase Pharmaceuticals, Inc. focus on?

Tetraphase Pharmaceuticals, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 12 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tetraphase ranks #23,517 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#23,517
of 50,000 US assignees by volume: Top 78%
by Innovation Score (26.9/100): 14.1
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23517 · US Corporation #23,517 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,517/50,000
PHOTO-FINISH Taymor Industries
CPC-NARROW A61P · 5 areas
INNOV-THIN 26.9/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Taymor Industries Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Tetraphase Pharmaceu… · this assignee

27
3D Lighting Innovati… · lowest

7

What this shows Tetraphase's Innovation Score is 26.9/100 (top 78% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Tetraphase's grants concentrate

Tetraphase Pharmaceuticals, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2019. By volume, Tetraphase sits between Taymor Industries Ltd. and The Ford Meter Box Company, Inc..

Taymor Industries

12
Techline

12
Techniks

12
Tektronix Texas

12
Texas Fueling Ser…

12
The Board of Trus…

12
The Council of th…

12
The Ford Meter Box

12
Tetraphase Pharma… ◀

12

What this shows Tetraphase holds 12 patents at rank #23,537, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tetraphase

By rank, the assignees closest to #23,537 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Tetraphase's primary technology class.

Tetraphase's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 Top 78% higher than 22% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Tetraphase Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	16.7%
2017	2	16.7%
2018	2	16.7%
2019	1	8.3%
2020	1	8.3%
2021	2	16.7%
2023	1	8.3%
2025partial year	1	8.3%

Which technologies does Tetraphase Pharmaceuticals, Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 12

C07D - HETEROCYCLIC COMPOUNDS 12

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 8

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 3

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 3

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#23,517

of 50,000 tracked assignees

Innovation Score

26.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.